Catalyst Wire Dossier Catalyst Wire Dossier

Denufosol

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Denufosol, covering 2015-01-13 to 2015-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment [Phase 2]

See pricing